CP and pneumococcal infection: The heightened levels of IFN-γ and IL-4 in BAL and serum samples from the mice treated with Cp 090104 or CP-derived BLPs during pneumococcal infection indicated an enhancement in the activation of Th1 and Th2 cellular immune defenses.